Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asfandyar Mufti

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
International Journal of Dermatology|February 7, 2022
Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic reviewJustin D Lu, Yuliya Lytvyn, Asfandyar Mufti, et al.
Journal of Cutaneous Medicine and Surgery|May 23, 2020
Short-Term Evaluation of the Real-World Efficacy and Safety of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis: A Canadian Multicenter Retrospective Cohort StudyChristine E Jo, Jorge R Georgakopoulos, Matthew Ladda, et al.
Journal of the American Academy of Dermatology|November 26, 2023
Risk of infections among patients with psoriasis on Janus kinase inhibitor treatment: A systematic review and meta-analysisNawar Tarafdar, Muskaan Sachdeva, Natnaiel M Dubale, et al.
Journal of Cutaneous Medicine and Surgery|November 16, 2023
The Rate of Infections With Janus Kinase Inhibitor Treatment for Atopic Dermatitis: A Systematic Review and Meta-AnalysisNawar Tarafdar, Muskaan Sachdeva, Natnaiel M Dubale, et al.
Journal of Cutaneous Medicine and Surgery|March 12, 2024
Onset of Vitiligo Within Patients Receiving Immune Checkpoint Inhibitors: An Evidence-Based ReviewAhmed Bagit, Muskaan Sachdeva, Siddhartha Sood, et al.
Journal of the American Academy of Dermatology|March 12, 2025
Disease severity and pruritus treatment outcomes in prurigo nodularis: A systematic review of randomized-controlled trialsRyan S Q Geng, Siddhartha Sood, Jihad Waked, et al.
The British Journal of Dermatology|December 22, 2023
Skin photoageing following sun exposure is associated with decreased epigenetic and biologic age, and correlates with basal cell carcinoma phenotypeRichie Jeremian, Alexandra Malinowski, Yuliya Lytvyn, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 12, 2025
<i>Letter:</i> Comorbidities of Prurigo Nodularis: A Systematic ReviewRyan S Q Geng, Siddhartha Sood, Jihad Waked, et al.
JAAD International|November 24, 2021
Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort studyYuliya Lytvyn, Asfandyar Mufti, Hiba Zaaroura, et al.
Journal of Cutaneous Medicine and Surgery|February 20, 2025
Severe Cutaneous Adverse Reactions Associated with Immune Checkpoint Inhibitors: A Systematic Review of Clinical Characteristics and ManagementSiddhartha Sood, Ahmed Bagit, Jihad Abou Ali Waked, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
International Journal of Dermatology|February 7, 2022
Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic reviewJustin D Lu, Yuliya Lytvyn, Asfandyar Mufti, et al.
Journal of Cutaneous Medicine and Surgery|May 23, 2020
Short-Term Evaluation of the Real-World Efficacy and Safety of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis: A Canadian Multicenter Retrospective Cohort StudyChristine E Jo, Jorge R Georgakopoulos, Matthew Ladda, et al.
Journal of the American Academy of Dermatology|November 26, 2023
Risk of infections among patients with psoriasis on Janus kinase inhibitor treatment: A systematic review and meta-analysisNawar Tarafdar, Muskaan Sachdeva, Natnaiel M Dubale, et al.
Journal of Cutaneous Medicine and Surgery|November 16, 2023
The Rate of Infections With Janus Kinase Inhibitor Treatment for Atopic Dermatitis: A Systematic Review and Meta-AnalysisNawar Tarafdar, Muskaan Sachdeva, Natnaiel M Dubale, et al.
Journal of Cutaneous Medicine and Surgery|March 12, 2024
Onset of Vitiligo Within Patients Receiving Immune Checkpoint Inhibitors: An Evidence-Based ReviewAhmed Bagit, Muskaan Sachdeva, Siddhartha Sood, et al.
Journal of the American Academy of Dermatology|March 12, 2025
Disease severity and pruritus treatment outcomes in prurigo nodularis: A systematic review of randomized-controlled trialsRyan S Q Geng, Siddhartha Sood, Jihad Waked, et al.
The British Journal of Dermatology|December 22, 2023
Skin photoageing following sun exposure is associated with decreased epigenetic and biologic age, and correlates with basal cell carcinoma phenotypeRichie Jeremian, Alexandra Malinowski, Yuliya Lytvyn, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 12, 2025
<i>Letter:</i> Comorbidities of Prurigo Nodularis: A Systematic ReviewRyan S Q Geng, Siddhartha Sood, Jihad Waked, et al.
JAAD International|November 24, 2021
Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort studyYuliya Lytvyn, Asfandyar Mufti, Hiba Zaaroura, et al.
Journal of Cutaneous Medicine and Surgery|February 20, 2025
Severe Cutaneous Adverse Reactions Associated with Immune Checkpoint Inhibitors: A Systematic Review of Clinical Characteristics and ManagementSiddhartha Sood, Ahmed Bagit, Jihad Abou Ali Waked, et al.
Pageof 15